Nortopixantrone

Nortopixantrone

SCHEMBL7804438

CNCCNc1ccc2c3c(nn2CCNCCO)-c2cnccc2C(=O)c13

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 7/20 0.61
TOP2B Q02880 1/20 0.43
ECE1 P42892 1/20 0.38
MUS81 Q96NY9 1/20 0.38
TP53 P04637 4/20 0.36
BLM P54132 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 3/20 0.36
USP2 O75604 3/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 3/20 0.36
RECQL P46063 3/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
NSD2 O96028 2/20 0.36
CYP3A4 P08684 2/20 0.36
CSNK2A1 P68400 2/20 0.36
NPC1 O15118 1/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nortopixantrone SCHEMBL29385196 1.00 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
Nortopixantrone SCHEMBL29711469 0.99 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7810460 0.96 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7811993 0.96 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7810474 0.94 TOP2A (0.68) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804826 0.93 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7811757 0.92 TOP2A (0.48) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804428 0.91 TOP2A (0.68) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804649 0.90 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7812099 0.90 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP claimed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP claimed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO claimed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP claimed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO claimed
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-6034092-A ANTITUMOR, ANTICANCER AGENTS NOVUSPHARMA S.P.A. (IT) 2000-03-07 US disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed